Lpl Financial LLC Edwards Lifesciences Corp Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lpl Financial LLC holds 240,461 shares of EW stock, worth $18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

240,461

Previous 322,351 25.4%

Holding current value

$18 Million

Previous $29.8 Million 46.71%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$59.7 - $93.78 $4.89 Million - $7.68 Million	-81,890 Reduced 25.4%	240,461 $15.9 Million
Q2 2024 Aug 07, 2024	BUY	$84.3 - $94.31 $78,146 - $87,425	927 Added 0.29%	322,351 $29.8 Million
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $978,492 - $1.29 Million	13,489 Added 4.38%	321,424 $30.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $357,547 - $450,541	5,794 Added 1.92%	307,935 $23.5 Million
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $483,574 - $651,792	6,980 Added 2.36%	302,141 $20.9 Million
Q2 2023 Jul 31, 2023	BUY	$81.41 - $94.33 $2.06 Million - $2.39 Million	25,324 Added 9.38%	295,161 $27.8 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $590,441 - $671,939	7,951 Added 3.04%	269,837 $22.3 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $36,199 - $46,343	530 Added 0.2%	261,886 $19.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $280,387 - $365,215	3,404 Added 1.32%	261,356 $21.6 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $1.64 Million - $2.43 Million	-18,967 Reduced 6.85%	257,952 $24.5 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $860,542 - $1.08 Million	-8,440 Reduced 2.96%	276,919 $32.6 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.33 Million - $2.87 Million	21,931 Added 8.33%	285,359 $37 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $2.95 Million - $3.52 Million	28,676 Added 12.22%	263,428 $29.8 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $146,636 - $183,225	1,749 Added 0.75%	234,752 $24.3 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $145,951 - $168,192	-1,855 Reduced 0.79%	233,003 $19.5 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $2.32 Million - $2.96 Million	32,398 Added 16.0%	234,858 $21.4 Million
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $824,421 - $1.07 Million	12,270 Added 6.45%	202,460 $16.2 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $7.75 Million - $10.4 Million	134,649 Added 242.43%	190,190 $13.1 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $290,456 - $448,902	5,542 Added 11.08%	55,541 $10.5 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $1.09 Million - $1.24 Million	15,148 Added 43.47%	49,999 $11.7 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $77,614 - $95,117	1,261 Added 3.75%	34,851 $7.66 Million
Q2 2019 Aug 09, 2019	BUY	$55.74 - $64.41 $233,327 - $269,620	4,186 Added 14.24%	33,590 $6.21 Million
Q1 2019 May 08, 2019	BUY	$47.89 - $64.05 $69,727 - $93,256	1,456 Added 5.21%	29,404 $5.63 Million
Q4 2018 Feb 07, 2019	BUY	$46.41 - $56.94 $500,810 - $614,439	10,791 Added 62.9%	27,948 $4.28 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $69,235 - $87,915	1,515 Added 9.69%	17,157 $2.99 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $125,864 - $152,104	-2,965 Reduced 15.93%	15,642 $2.28 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $80,330 - $102,492	2,160 Added 13.13%	18,607 $2.6 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $39,737 - $46,322	1,176 Added 7.7%	16,447 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $2,249 - $2,407	62 Added 0.41%	15,271 $1.67 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,209	15,209 $1.8 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Edwards Lifesciences Corp Transaction History